Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Lisata Therapeutics's gross margin for the twelve months ending Mar 31, 2017 was 7.7%. For fiscal 2016 it was 11.8%, against 10.4% the year before. The highest annual figure on record is 28.9% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | 11.8% | +1.4 |
| FY2015 | Dec 31, 2015 | 10.4% | −2.2 |
| FY2014 | Dec 31, 2014 | 12.6% | +0.9 |
| FY2013 | Dec 31, 2013 | 11.7% | −4.9 |
| FY2012 | Dec 31, 2012 | 16.6% | +2.6 |
| FY2011 | Dec 31, 2011 | 14.0% | −14.9 |
| FY2010 | Dec 31, 2010 | 28.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2017 | Mar 31, 2017 | -1.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 9.2% | – |
See a number that looks wrong?